Personalis, Inc. - Common Stock (PSNL)
5.2650
-0.0950 (-1.77%)
Personalis Inc is a biotechnology company that specializes in advanced genomics and personalized medicine
The firm focuses on providing comprehensive genomic profiling services to aid in the detection and treatment of cancer. Through its proprietary technologies, Personalis analyzes a patient's unique genetic makeup to deliver insights that support personalized therapeutic decisions and improve patient outcomes. The company's offerings are aimed at healthcare providers, researchers, and pharmaceutical companies seeking to leverage genomic data for better understanding and addressing complex diseases, particularly in oncology.
Frequently Asked Questions
Is Personalis, Inc. - Common Stock publicly traded?
Yes, Personalis, Inc. - Common Stock is publicly traded.
What exchange does Personalis, Inc. - Common Stock trade on?
Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Personalis, Inc. - Common Stock?
The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market
What is the current price of Personalis, Inc. - Common Stock?
The current price of Personalis, Inc. - Common Stock is 5.265
When was Personalis, Inc. - Common Stock last traded?
The last trade of Personalis, Inc. - Common Stock was at 3:51 pm EST on January 31st, 2025
What is the market capitalization of Personalis, Inc. - Common Stock?
The market capitalization of Personalis, Inc. - Common Stock is 255.45M
How many shares of Personalis, Inc. - Common Stock are outstanding?
Personalis, Inc. - Common Stock has 48.52M shares outstanding.